GFI1(36N) as a therapeutic and prognostic marker for myelodysplastic syndrome (MDS) by Botezatu, L, Michel, L, Makishima, H, Schroeder, T, Germing, U, Haas, R, van der Reijden, B, Marneth, A, Bergevoet, S, Jansen, J, Przychodzen, B, Wlodarski, M, Niemeyer, C, Platzbecker, U, Ehninger, G, Unnikrishnan, A, Beck, D, Pimanda, J, Hellström-Lindberg, E, Cazzola, M, Malcovati, L, Boultwood, J, Pellagatti, A, Papaemmanuil, E, Le Coutre, P, Kaeda, J, Opalka, B, Möröy, T, Dührsen, U, Maciejewski, J, Khandanpour, C